ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 6

Ro52/Trim21 Influences Follicular B Cell Homeostasis and Immunoglobulin Production

Margarita Ivanchenko1, Susanna Brauner2, Gudny Ella Thorlacius1, Aurélie Ambrosi1 and Marie Wahren-Herlenius1, 1Unit of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 2Neuroimmunology Unit, Department of Clinical Neurosciences, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, Solna, Sweden

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: autoantibodies, B cells, immune response and systemic lupus erythematosus (SLE), Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: B Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic rheumatic diseases are characterized by abnormal B cell activation with autoantibody production and hypergammaglobulinemia. The autoantigen Ro52/SSA, also denoted TRIM21, is a major autoantigen in Sjögren’s syndrome and systemic lupus erythematosus. Interestingly, Trim21-deficient mice develop systemic autoimmunity with B cell-related features such as autoantibodies, hypergammaglobulinemia and glomerulonephritis following tissue injury. The mechanisms by which Trim21 deficiency leads to enhanced B cell activation and antibody production are not well understood, and to further elucidate the role of Trim21 in systemic autoimmunity we investigated the B cell phenotype of Trim21-/- mice.

Methods: Littermate C57BL/6J Trim21+/+ and Trim21-/- mice were immunized with antigens eliciting thymus-dependent or thymus-independent B cell responses: nitrophenol-coupled ovalbumin (NP-OVA), lipopolysaccharide (NP-LPS) and ficoll (NP-ficoll). Anti-NP-IgM and IgG antibody titers were measured by ELISA, and B cell subpopulations were assessed by flow cytometry. CD19+ splenic cells from naïve mice were sorted and stimulated with anti-IgM antibodies, and proliferation was estimated by H3-thymidine incorporation and Ki67 expression. CD19+CD21+CD23high follicular B cells were isolated from naïve mice and subjected to RNA extraction and microarray analysis.

Results: Higher specific IgG and IgM antibody titers were detected in Trim21-/- mice compared to wild-type littermates upon immunization with NP-OVA and NP-ficoll. Consistent with these observations, NP-OVA-immunized Trim21-/- mice had higher frequencies of splenic follicular (CD19+CD21+CD23high) cells and bone marrow plasma (CD19–CD138+) cells. B cell receptor-specific stimulation of naïve splenic B cells in vitro resulted in significantly higher proliferation of Trim21-/- cells. We also observed that splenic follicular B cells were more frequent already in naïve Trim21-/- mice. Transcriptome analysis of these cells revealed differential regulation of genes associated with B cell differentiation, proliferation and metabolism.

Conclusion: Our findings reveal a link between the rheumatic autoantigen Ro52/Trim21 and increased antibody production associated with expansion of follicular B cells, suggesting a potential role for this autoantigen in the pathogenesis of systemic autoimmunity.


Disclosure: M. Ivanchenko, None; S. Brauner, None; G. E. Thorlacius, None; A. Ambrosi, None; M. Wahren-Herlenius, None.

To cite this abstract in AMA style:

Ivanchenko M, Brauner S, Thorlacius GE, Ambrosi A, Wahren-Herlenius M. Ro52/Trim21 Influences Follicular B Cell Homeostasis and Immunoglobulin Production [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/ro52-trim21-influences-follicular-b-cell-homeostasis-and-immunoglobulin-production/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ro52-trim21-influences-follicular-b-cell-homeostasis-and-immunoglobulin-production/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology